Effects of the Treatment of Dong Medicine Five-Flavour Anti-Diarrhoea Soup Combined with Melalazine on Serum Complement C3, C4, Interleukin-23 and Interleukin-17 in Patients with Ulcerative Colitis

نویسندگان

چکیده

To investigate the clinical effect of treatment dong medicine five-flavor anti-diarrhea soup combined with melalazine on chronic recurrence type (spleen deficiency and dampness accumulation type) ulcerative colitis. A total 60 patients conforming to diagnostic criteria traditional Chinese Western in anorectal department gastroenterology First Affiliated Hospital, Guizhou University Traditional Medicine from September 2019 December 2020 were randomly selected grouped. Patients group took enteric tablets (30 patients). control received oral intestinal-soluble Changes medical syndrome scores, Baron endoscopic Mayo serum complement C3 C4, interleukin-23 interleukin-17 recorded before after 8 w groups, symptoms observed recorded. The was better than improving points symptoms, scores reducing C4 levels, which demonstrated as statistically significant (p<0.05). effects melalazin colitis are that regarding remission various medicine, reduction C3, levels.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Serum Interleukin-23 Levels in Patients with Ulcerative Colitis

Background: Patients with ulcerative colitis are at increased risk of inflammation. Interleukin 23 (IL-23) is a newly identified cytokine with increased expression in inflamed biopsies of colon mucosa in patients with Crohn's disease; however, there is inconsistent evidence on its role in ulcerative colitis. Objective: We aimed to compare serum IL-23 level in patients with ulcerative colitis an...

متن کامل

Interleukin-17 Serum Levels and TLR4 Polymorphisms in Ulcerative Colitis

Background: Inflammatory bowel disease, an autoimmune disease, has two clinical manifestations including Crohn’s disease and ulcerative colitis (UC). IL-17 has been the target of intensive research in autoimmune diseases. The influence of Toll like receptor 4 (TLR-4) gene polymorphisms on IL-17 production has also been revealed in UC patients and tissue inflammation in mice. Objectives: To inve...

متن کامل

Serum interleukin-23 levels in patients with ulcerative colitis.

BACKGROUND Patients with ulcerative colitis are at increased risk of inflammation. Interleukin 23 (IL-23) is a newly identified cytokine with increased expression in inflamed biopsies of colon mucosa in patients with Crohn's disease; however, there is inconsistent evidence on its role in ulcerative colitis. OBJECTIVE We aimed to compare serum IL-23 level in patients with ulcerative colitis an...

متن کامل

Serum Interleukin-17 Evaluation in Patients With Eosinophilic Gastrointestinal Disease

Background: Eosinophilic gastrointestinal disorders or diseases (EGIDs) may result from an abnormal immune-mediated response to food antigens. Activated eosinophils release various mediators with inflammatory properties which may result in tissue and subsequently organ damage. The cytokine milieu of these patients has revealed increased levels of pro-inflammatory cytokines, inc...

متن کامل

Effects of Non-Surgical Periodontal Therapy on Gingival Crevicular Fluid Levels of Interleukin-17 and Interleukin-23 in Patients with Periodontitis: A Clinical Trial

Background and Aim: Considering the critical role of inflammatory responses in periodontal disease, knowledge about the immune system and cytokines seems nec-essary. The aim of this study was to evaluate the level of IL-23 and IL-17 in gingival crevicular fluid (GCF) of patients with chronic and aggressive periodontitis, before and after non-surgical periodontal therapy. Materials and Methods:...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Indian Journal of Pharmaceutical Sciences

سال: 2022

ISSN: ['0250-474X', '1998-3743']

DOI: https://doi.org/10.36468/pharmaceutical-sciences.spl.523